Assignee
ASKLEPION PHARMACEUTICALS LLC
US·2 granted patents·3 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
5 records- 0163US2025170084A1Action of l-citrulline to prevent or treat endothelial dysfunctionASKLEPION PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0259US12064409B2Action of L-citrulline to prevent or treat endothelial dysfunctionASKLEPION PHARMACEUTICALS LLC·Filed 2021·Granted Aug 20, 2024·0 cites·20 claims
- 0352US12240801B2Method of synthesis and purification of citrullineASKLEPION PHARMACEUTICALS LLC·Filed 2020·Granted Mar 4, 2025·0 cites·4 claims
- 0451US2023404956A1Therapeutic window for citrulline therapyASKLEPION PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 0551US2025179011A1Improved method of synthesis and purification of citrullineASKLEPION PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →